Anju Software, a clinical, medical affairs and commercial software and data platform for the life sciences industry, has received a debt investment from J.P. Morgan’s Technology Middle Market Commercial Banking group.
- The new capital infusion will support the Company’s M&A strategy as it seeks to consolidate the fragmented life sciences software market
- The company’s suite of best-in-breed software products enable users to manage mission-critical pharma processes across pre-market and post-market functions.
- Anju is backed by Providence Strategic Growth, the technology growth equity arm of Providence Equity.
About Anju Software
Anju Software is a leading provider of comprehensive software solutions to the life sciences industry. Anju provides an integrated platform spanning clinical, medical affairs and commercial operations. Anju solutions are used by large and small pharmaceutical companies, clinical research organizations (CRO), full service agencies and medical device companies. Data flow between functional areas, seamless communication with third party systems and AI-based data mining solutions to provide customers critical information throughout their ecosystem.
About JPMorgan Chase (NYSE: JPM)
JPMorgan Chase & Co. (NYSE: JPM) is a leading global financial services firm with assets of $2.5 trillion and operations worldwide. The firm is a leader in investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing, and asset management. A component of the Dow Jones Industrial Average, JPMorgan Chase & Co. serves millions of customers in the United States and many of the world’s most prominent corporate, institutional and government clients under its J.P. Morgan and Chase brands.
About Providence Strategic Growth
Providence is a premier asset management firm with over $40 billion in aggregate capital commitments. Providence pioneered a sector-focused approach to private equity investing with the vision that a dedicated team of industry experts could build exceptional companies of enduring value. Since the firm’s inception in 1989, Providence has invested in over 180 companies and has become a leading equity investment firm focused on the media, communications, education and information industries.
- 9 Transactions
- 6 Years of Partnership
SectorsHealthcare & Life Sciences Technologies
PracticesHealthcare & Life Sciences TechnologySponsor Coverage
MPG Transaction LeaderRohan Khanna